11041149

2 known cases. View patent page →

Halozyme, Inc. v. Merck Sharp & Dohme Corp. et al.

Ongoing
Docket:
2:25-cv-03179 (ES) (JRA)
Filed:
2025-04-24
Patents:11041149

Halozyme, Inc. sued Merck Sharp & Dohme Corp. (now Merck Sharp and Dohme LLC), alleging that Merck's subcutaneous KEYTRUDA® formulation infringes 15 of Halozyme's patents, including US 11041149. Halozyme seeks damages and injunctive relief to block commercialization of SC Keytruda, also alleging willful infringement.